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Abstract 
An 83-year-old Japanese man presented with a 2-month history of symptomatic nodules on 
the left hand. He was not in an immunocompromised condition and reported no causal 
events. A biopsy specimen demonstrated granulomatous tissue with mixed cell infiltration 
consisting of neutrophils, histiocytes, lymphocytes, and multinuclear giant cells. No bacillus 
was detected by PAS, acid-fast stain, immunofluorescent stain or polymerase chain reaction 
analysis. The isolate was found to be a rapidly growing mycobacterium after 4 weeks of 
incubation at 25°C on an Ogawa egg slant. Mycobacterium peregrinum was isolated by DNA-
DNA hybridization analysis, 16S rRNA gene sequence, and by its production of 3-day 
arylsulfatase. The patient received 200 mg oral minocycline for 28 weeks. The lesion 
disappeared after 10 weeks of this treatment. 
 
Introduction 
Mycobacterium (M.) peregrinum, an opportunistic, rapidly growing mycobacterium 
(RGM), belongs to the M. fortuitum group. Because patients with cutaneous infection 
due to M. peregrinum are rare, the clinical information on this mycobacterium is limited 
[1, 2].  
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Case Report 
An 83-year-old Japanese man presented with a 2-month history of symptomatic nodules on the left 
hand. He was not in an immunocompromised condition and reported no causal events related to 
infection, including preceding trauma, fish breeding or circulating bath. On examination, an 
erythematous plaque with an ulcer and pustules 3 cm in size was seen on the dorsal aspect of the left 
hand (fig. 1). The superficial lymph node was not palpable. The results of laboratory examinations 
were within the normal range. Chest X-ray ruled out any pulmonary problems. A biopsy specimen 
from the hand demonstrated granulomatous tissue with mixed cell infiltration consisting of 
neutrophils, histiocytes, lymphocytes, and multinuclear giant cells (fig. 2). No bacillus was detected 
by PAS, acid-fast stain, immunofluorescent stain or polymerase chain reaction analysis. The isolate 
was found to be an RGM after 4 weeks of incubation at 25°C on an Ogawa egg slant. M. peregrinum 
was isolated by DNA-DNA hybridization analysis, 16S rRNA gene sequence, and by its production of 3-
day arylsulfatase [3]. 
The patient received 200 mg oral minocycline (MINO) for 28 weeks. The lesion progressively 
shrank during the treatment and then disappeared after 10 weeks of treatment, leaving only a few 
scars. No recurrence was observed 1 year after his first visit. 
Discussion 
In recent years, the pathogenic potential of RGM has gained attention. Although they 
are not usually pathogenic in humans, they can cause disease in individuals with or 
without an immunocompromised condition and in people who have had traumatic 
accidents, such as tsunami survivors with late-onset skin or soft-tissue infections [4]. M. 
abscessus and M. fortuitum are the most commonly detected RGM in skin infections, and 
M. peregrinum is rarely identified. Thus, the clinical information, especially regarding 
treatment, has not been fully examined. Table 1 lists the cases of M. peregrinum with 
skin lesions that have been reported [2, 4–8]. There were no patients with 
immunocompromised conditions. All patients were successfully treated with 
combinations of sparfloxacin (SPFX) and MINO; amikacin (AMK), imipenem-cilastatin 
(IMP/CS) and levofloxacin (LVFX); AMK, clarithromycin (CAM) and ciprofloxacin 
(CPFX); and CAM and LVFX, except our patient, who was treated with MINO 
monotherapy. For treatment of infections caused by M. fortuitum group mycobacteria 
including M. peregrinum, the Johns Hopkins Antibiotics Guide recommends oral 
monotherapy with sulfonamide, doxycycline (DOXY), or CAM for limited or localized 
wound infections and the combination of at least 2 agents including AMK plus either a 
β-lactam or quinolone for severe infections of the skin, soft tissue or bone, and for 
pulmonary disease [9]. Han et al. [1] reported that antimicrobial susceptibility varied 
among the species of RGM. The results in 105 strains showed that AMK was most active 
against M. abscessus, M. chelonae and the M. fortuitum group. CAM was the second most 
active drug for most RGM, except in the case of M. fortuitum. Less than half of the 
strains showed susceptibility to DOXY and MINO, and none of the 6 strains of M. 
peregrinum or Clostridium septicum showed sensitivity to these 2 antibiotics. Because 
most of these strains were isolated from respiratory sources or blood cultures in cancer 
patients, the data might not apply to cases of skin infection in patients without an 
immunocompromised condition. Although monotherapy with MINO was effective in 
our case, combination therapy should be performed routinely. Further case reports 
involving clinical evaluations of antibiotics are necessary to determine an appropriate 
therapy for rare mycobacterial infections.  
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Table 1. Patients with M. peregrinum skin lesions 
                       
                       
No.  Year  Age/ 
sex 
Country  Site of infection  
(causing event) 
Location  Immuno- 
deficiency 
Chronic 
disease 
Antibiotics  Duration of 
treatment 
Surgical 
procedure 
Ref 
no. 
                       
                       
1  1983  NR  USA  after mammoplasty  NR  –  NR  NR  NR  NR  5 
2  1998  45/M  Japan  skin and soft tissue  left arm  –  –  SPFX, MINO  15 weeks  –  2 
3  1998  NR  France  skin and soft tissue 
(subcutaneous  
insulin infusion) 
NR  –  NR  NR  NR  NR  6 
4  1999  >65/F  Japan  skin  NR  NR  NR  NR  NR  NR  10 
5  2003  67/F  Japan  skin  back of  
left hand  
NR  NR  NR  NR  NR  11 
6  2006  NR  Spain  skin and soft tissue  
(mesotherapy) 
NR  –  NR  CPFX  3–4 months  –  7 
7  2009  58/F  Japan  skin and soft tissue 
(reconstruction of 
abdominal wall) 
right chest 
wall 
–  NR  AMK, IMP/CS, LVFX  5 weeks  removal of 
artificial  
sheet 
8 
8  2008  40/M  Sweden  skin  NR  –  NR  AMK, CAM, CPFX  3–6 months?  suture  4 
9  2011  78/M  Japan  skin  back of  
right hand 
–  chronic  
gastritis 
CAM, LVFX  12 weeks  –  12 
Present 
case 
2011  83/M  Japan  skin  back of  
left hand 
–  hypertension  MINO  28 weeks  –   
                       
                       
NR = Not recorded. 
  
 
 
 
 
 
Fig. 1. Plaque with ulcer on the left hand. 
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Fig. 2. Biopsy specimen demonstrated granulomatous tissue with mixed cell infiltration consisting of 
neutrophils, histiocytes, lymphocytes, and multinuclear giant cells. 
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